Hinge Health IPO Soars 17% Despite Down-Round Valuation

Hinge Health IPO Soars 17% Despite Down-Round Valuation

Hinge Health IPO Surges 17% on NYSE Debut Despite Lower Valuation Investors searching for Hinge Health IPO performance or wondering whether Hinge Health stock is a good investment in 2025 will find the latest market debut both promising and telling. The digital physical therapy company closed its first day of trading on the New York Stock Exchange at $37.56 , marking a 17% jump over its IPO price of $32 . This opening day surge reflects strong investor interest in digital health startups, even as Hinge Health joins the swelling ranks of down-round IPOs —public offerings where the company's valuation is lower than its last private funding round.                   Image Credits:Hinge Health Despite its first-day success, Hinge Health enters the public market with a market cap of around $3 billion , less than half of its $6.2 billion valuation in 2021 , achieved during a bullish Series E led by Tiger Global Management. For context, this kind of valuation drop, once seen as a red flag, is inc…